Variational AI will participate in BIOPLUS-INTERPHEX KOREA 2026 (BIX 2026), taking place October 28 to 30, 2026 at COEX in Seoul, South Korea. Hosted by KoreaBIO and organized by RX Korea, BIX is Korea’s principal biopharmaceutical exhibition and convention, spanning the full value chain from research and development through manufacturing, digital health, and global business development. The 2026 edition is expected to draw more than 10,000 visitors and 300 exhibitors, with over 30 conference sessions and a one-to-one partnering platform.
Canada has been confirmed as Country of Honour for BIX 2026, placing Canadian life sciences companies at the centre of the exhibition and conference program, with a coordinated delegation program supported by the Embassy of Canada in Seoul.
Korea is one of the most active regions for small-molecule and proximity-based therapeutic development, and several Korean groups are building programs in degraders, molecular glues, and ADC payloads. These are areas Enki™ was extended to cover in its most recent release.
Meet the team
Handol Kim, Co-Founder & CEO
Valentin Beuchillot, Director of Business Development & Marketing
We will be taking partnering meetings throughout the event to discuss AI-enabled lead finding and lead generation for programs in Korea and across the region.
Meet the team
If you are attending BIX 2026 or joining the Canadian delegation program, reach out to bd@variational.ai to schedule time. Meetings can also be requested through the BIX partnering platform.